![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Liver Cirrhosis |
|
Free Subscription
17 BMC Gastroenterol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Liver Cirrhosis is free of charge.
I-FABP, citrulline and non-invasive liver dysfunction indices in patients with
depression - cross-sectional study results.
BMC Gastroenterol. 2026;26:88.
PubMed
Abstract available
Impact of preoperative triglyceride levels on hepatic encephalopathy development
in TIPS patients: a retrospective cohort study.
BMC Gastroenterol. 2026 Jan 12. doi: 10.1186/s12876-025-04583.
PubMed
Abstract available
Risk factors for significant hepatic fibrosis in alcoholic liver disease and
construction of a nomogram prediction model.
BMC Gastroenterol. 2026 Feb 2. doi: 10.1186/s12876-026-04606.
PubMed
Direct bilirubin was superior to total bilirubin in predicting the long-term
outcomes of patients with primary biliary cholangitis.
BMC Gastroenterol. 2026 Feb 11. doi: 10.1186/s12876-026-04667.
PubMed
Leptin, vitamin D, and APRI values during the six months post-liver
transplantation.
BMC Gastroenterol. 2026;26:145.
PubMed
Abstract available
High-intensity hydrophilic versus lipophilic statins in patients with primary
biliary cholangitis: a multi-institutional analysis.
BMC Gastroenterol. 2026 Mar 10. doi: 10.1186/s12876-026-04723.
PubMed
Autoantibody profiles and fibrosis indices across HBV-related disease stages: a
retrospective laboratory-based study in a tertiary hospital in China.
BMC Gastroenterol. 2026;26:238.
PubMed
Abstract available
Extracellular vesicles derived from live or apoptotic mesenchymal stem cells:
comparison of the effects of two extracellular vesicles on liver fibrosis.
BMC Gastroenterol. 2026;26:265.
PubMed
Abstract available
Metabolic dysfunction-associated steatohepatitis in the real world: clinical
burden, disease progression, and risk stratification with non-invasive tests.
BMC Gastroenterol. 2026 Mar 26. doi: 10.1186/s12876-026-04745.
PubMed
Fibrotic, metabolic and clinical improvements in patients with chronic hepatitis
C treated with direct-acting antiviral therapy in a resource limited setting: a
prospective cohort study.
BMC Gastroenterol. 2026 Apr 1. doi: 10.1186/s12876-026-04776.
PubMed
Vitamin D receptor gene polymorphism and its association with the susceptibility
to Helicobacter pylori infection in the Egyptian population with hepatocellular
carcinoma.
BMC Gastroenterol. 2026 Apr 2. doi: 10.1186/s12876-026-04740.
PubMed
Association of metabolic syndrome and its severity with liver fibrosis: a
cross-sectional study based on NHANES 2017-March 2020, 2021-2023.
BMC Gastroenterol. 2026;26:296.
PubMed
Abstract available
Vitamin D deficiency in chronic hepatitis B across the disease spectrum:
association with viral activity rather than hepatocellular carcinoma.
BMC Gastroenterol. 2026 Apr 11. doi: 10.1186/s12876-026-04808.
PubMed
Blood-based non-invasive tests show comparable accuracy in MetALD and MASLD for
MRE-defined advanced fibrosis.
BMC Gastroenterol. 2026;26:329.
PubMed
Abstract available
Dual-phase T1-mapping (DHR-MAP) for non-invasive assessment of advanced liver
fibrosis and moderate hepatitis: a single-center validation study.
BMC Gastroenterol. 2026 May 9. doi: 10.1186/s12876-025-04581.
PubMed
Abstract available
The impact of metabolic dysfunction-associated steatotic liver disease on
non-invasive fibrosis scores in patients with chronic hepatitis B: a multicenter
retrospective study.
BMC Gastroenterol. 2026 May 29. doi: 10.1186/s12876-026-04959.
PubMed
Abstract available
The effect of TIPS on the development of hepatocellular carcinoma in patients
with cirrhosis: a meta-analysis.
BMC Gastroenterol. 2026 Jun 29. doi: 10.1186/s12876-026-05027.
PubMed
Abstract available
Clin Res Hepatol Gastroenterol
Burden and Distribution of Multidrug-Resistant Bacteria Among Hospitalized
Patients with Cirrhosis: A Systematic Review and Meta-Analysis.
Clin Res Hepatol Gastroenterol. 2026 Jun 30:102877.
PubMed
Abstract available
Anserine restores antibacterial immunity in cirrhosis via a protective
CCL5-mediated hepatocyte-CD44(+)pDC crosstalk.
J Hepatol. 2026 Jul 1:S0168-8278(26)02680-2. doi: 10.1016/j.jhep.2026.
PubMed
Abstract available
Cirrhosis outcomes on rurality and weekend admissions revisited: A contemporary
analysis of the national inpatient sample.
PLoS One. 2026;21:e0353178.
PubMed
Abstract available
Thank you for your interest in scientific medicine.